Skip to Content

Join the 'Triesence' group to help and get support from people like you.

Triesence News

Knee Arthritis: Steroid Shots May Not Help Long-Term, Ozone Injections Promising

Posted 10 Nov 2015 by Drugs.com

TUESDAY, Nov. 10, 2015 – Millions of aging Americans are plagued by arthritic knees, and two new studies offer insight into what might – or might not – help curb the condition. Both studies were presented this week at the American College of Rheumatology's annual meeting in San Francisco. One study found that a popular therapy, steroid drug injections, do nothing to slow progression of osteoarthritis in the knee. This type of treatment is common, but has never been specifically tested, and there are concerns about its safety, according to a team led by Dr. Tim McAlindon, chief of rheumatology at Tufts Medical Center in Boston. His team tracked outcomes for 140 people – mainly overweight white women – with knee arthritis who averaged 58 years of age. The patients received either injections of the steroid triamcinolone hexacetonide, or placebo injections of saline, every three months ... Read more

Related support groups: Prednisone, Osteoarthritis, Testosterone, Methylprednisolone, Prednisolone, AndroGel, Hydrocortisone, Medrol, Cortisone, Dexamethasone, Triamcinolone, Testim, Betamethasone, Axiron, Budesonide, Decadron, Kenalog, Entocort, Nasacort, Solu-Medrol

FDA Medwatch Alert: Brilliant Blue G Compounded by Franck's: Recall of Unapproved Drug - Ongoing Investigation of Fungal Endophthalmitis Cases

Posted 23 Apr 2012 by Drugs.com

  [UPDATED 04/20/2012] FDA issues second warning to physicians regarding cvertain compounded drugs from Franck's. FDA received reports of eye infections in patients who were given injections of drug products containing triamcinolone during eye surgery.   [Posted 03/19/2012] ISSUE: FDA has received reports of fungal endophthalmitis (eye infections) in patients who were given Brilliant Blue G (BBG), supplied by Franck's Pharmacy, during eye surgeries. Clinicians in several states reported the adverse events. FDA, along with CDC and local and state public health agencies, are actively investigating these adverse events. BACKGROUND: The BBG was supplied by Franck’s Compounding Lab, Ocala, Florida. Franck’s Pharmacy issued a recall on March 9, 2012, of all lots of Brilliant Blue G and issued a recall letter (link below). Brilliant Blue G is not an approved drug in the U.S.  RECOMMENDATION: I ... Read more

Related support groups: Trivaris, Triesence

FDA Medwatch Alert: Certain Compounded Drugs from Franck's: FDA Issues Second Warning to Physicians

Posted 23 Apr 2012 by Drugs.com

Brilliant Blue G (BBG) Triamcinolone   [Posted 04/20/2012] ISSUE: FDA has received additional reports of fungal endophthalmitis (eye infections) in patients who were given Brilliant Blue G (BBG) during eye surgery since the FDA Warning to Physicians was posted on March 19, 2012. The agency has also recently received reports of eye infections in patients who were given injections of drug products containing triamcinolone during eye surgery. BACKGROUND: Clinicians in several states reported the adverse events. FDA, CDC, and local and state public health agencies are actively investigating these incidents. These drugs were supplied by Franck’s Pharmacy in Ocala, Florida. Brilliant Blue G is not an approved drug in the United States. Franck’s has recalled all lots of BBG and one lot of Triamcinolone Acetonide P.F RECOMMENDATION: The Centers for Disease Control and Prevention (CDC) has adv ... Read more

Related support groups: Trivaris, Triesence

Steroid Restores Vision When Veins in Eye Become Blocked

Posted 2 Feb 2010 by Drugs.com

TUESDAY, Sept. 15 – Researchers report they've found the first long-term treatment for people who suffer vision loss when the large veins in their eyes become blocked. "These are extremely compelling results, because a large, longer-term clinical trial has never before shown that patients with central retinal vein occlusion could experience a visual improvement with treatment," Dr. Michael S. Ip, chair of the study and an associate professor at the University of Wisconsin, Madison, said in a news release from the National Eye Institute. The institute funded the research. The study authors found that injections into the eye of a corticosteroid – a steroid medication often used to reduce inflammation – improved vision in patients. After a year, they were five times more likely to have regained vision than those who were simply observed. This is the first effective treatment for the ... Read more

Related support groups: Retinal Disorders, Trivaris, Triesence

Steroid Shots Tested to Treat Diabetes-Related Eye Disease

Posted 17 Dec 2009 by Drugs.com

WEDNESDAY, Dec. 16 – Injecting steroids into the eye may slow the progression of diabetes-related eye disease, but should not be counted on as a treatment at this time, researchers say. Diabetic retinopathy, which can cause vision loss and blindness, occurs when new blood vessels form in the retina. The condition affects about 700,000 Americans, and 63,000 new cases develop each year, according to background information provided in the study. Control of blood glucose levels can help prevent the disease, and laser treatments can help lower the risk of vision loss, but researchers continue to search for new treatments. In the new study, researchers tested different therapies on 840 eyes of 693 patients with macular edema, a leakage of fluid into part of the retina, which often occurs in retinopathy. The eyes received one of three treatments: photocoagulation – a laser treatment that ... Read more

Related support groups: Diabetic Retinopathy, Trivaris, Retinopathy Prophylaxis, Triesence

Ask a Question

Further Information

Related Condition Support Groups

Vitrectomy, Temporal Arteritis, Uveitis

Triesence Patient Information at Drugs.com